Literature DB >> 17188477

Fascinating metabolic pools of Pelargonium sidoides and Pelargonium reniforme, traditional and phytomedicinal sources of the herbal medicine Umckaloabo.

Herbert Kolodziej1.   

Abstract

The metabolic pools of Pelargonium sidoides DC and Pelargonium reniforme CURT, associated with the origin of the herbal medicine Umckaloabo, exhibit remarkable diversity and complexity. They comprise a variety of phenolic and polyphenolic compounds, a notable wealth of highly oxygenated simple coumarins and a number of miscellaneous uncommon metabolites. Noteworthy, the roots of both species express conspicuously distinct coumarin variations that facilitate their identification. Of the range of coumarins identified the titled species shared the ubiquitous scopoletin and the unique members 6,7,8-trihydroxycoumarin and 8-hydroxy-5,6,7-trimethoxycoumarin merely. Furthermore, the current data on the coumarin profiles suggest the occurrence of coumarin sulphates and coumarin glycosides to be apparently confined to P. sidoides, while the occurrence of conventional proanthocyanidins was a common chemical feature. An unprecedented diterpene, designated as reniformin, was encountered in the roots of P. reniforme, possessing a novel diterpene skeleton linked to a unique p-oxyphenethansulfonic moiety. Coumarins were less abundant in the aerial parts of both species. These were rich in flavonoids and hydrolysable tannins including a unique series of O-galloyl-C-glucosylflavones (P. sidoides and P. reniforme) and novel ellagitannins with a (1)C(4) glucopyranose core in P. reniforme, trivially named pelargoniins, accompanied by the new 4-allyl-2,5-dimethoxyphenol-1-beta-D-glucoside. These Pelargoniums have thus represented an attractive source of fascinating secondary metabolites. A proprietary extract of the roots of P. sidoides, EPs 7630, has been developed from this traditional herbal medicine and introduced into modern phytotherapy in Europe. Structural examination of EPs 7630 constituents showed excellent agreement of the profile with that of P. sidoides.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17188477     DOI: 10.1016/j.phymed.2006.11.021

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  23 in total

1.  Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology.

Authors:  A S P Pereira; M J Bester; Z Apostolides
Journal:  Mol Divers       Date:  2017-09-18       Impact factor: 2.943

2.  Tremella fuciformis Inhibits Melanogenesis in B16F10 Cells and Promotes Migration of Human Fibroblasts and Keratinocytes.

Authors:  Jo-Hua Chiang; Fuu-Jen Tsai; Tsai-Hsiu Lin; Jai-Sing Yang; Yu-Jen Chiu
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

Review 3.  [Pelargonium sidoides-extract (EPs 7630): registration confirms efficacy and safety].

Authors:  Andreas Conrad; Herbert Kolodziej; Volker Schulz
Journal:  Wien Med Wochenschr       Date:  2007

4.  Anti-inflammatory Effects of Pelargonium endlicherianum Fenzl. Extracts in Lipopolysaccharide-stimulated Macrophages.

Authors:  Ahmet Cumaoğlu; Gökçe Şeker Karatoprak; Mükerrem Betül Yerer; Müberra Koşar
Journal:  Turk J Pharm Sci       Date:  2018-04-02

5.  The root extract of the medicinal plant Pelargonium sidoides is a potent HIV-1 attachment inhibitor.

Authors:  Markus Helfer; Herwig Koppensteiner; Martha Schneider; Stephanie Rebensburg; Sara Forcisi; Constanze Müller; Philippe Schmitt-Kopplin; Michael Schindler; Ruth Brack-Werner
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

Review 6.  Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs® 7630) in the Context of Health Promotion.

Authors:  Herbert Kolodziej
Journal:  Pharmaceuticals (Basel)       Date:  2011-10-10

7.  Gastroprotective efficacy and safety evaluation of scoparone derivatives on experimentally induced gastric lesions in rodents.

Authors:  Dong Ju Son; Gyung Rak Lee; Sungil Oh; Sung Eun Lee; Won Sik Choi
Journal:  Nutrients       Date:  2015-03-13       Impact factor: 5.717

8.  Efficacy and tolerability of EPs 7630 in patients (aged 6-18 years old) with acute bronchitis.

Authors:  W Kamin; V G Maydannik; F A Malek; M Kieser
Journal:  Acta Paediatr       Date:  2010-01-11       Impact factor: 2.299

9.  The Pelargonium sidoides Extract EPs 7630 Drives the Innate Immune Defense by Activating Selected MAP Kinase Pathways in Human Monocytes.

Authors:  Katrin Witte; Egon Koch; Hans-Dieter Volk; Kerstin Wolk; Robert Sabat
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

Review 10.  Traditional medicines in Africa: an appraisal of ten potent african medicinal plants.

Authors:  M Fawzi Mahomoodally
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-03       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.